MS
Morgan Stanley
MS has the edge over NECB overall, supported by stronger fundamentals and stronger modeled upside.
NECB
Northeast Community Bancorp, Inc.
NECB's outlook is improving, though it still trails on the overall score.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
NECB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
NECB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NECB.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
NECB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $18.52 | -36% |
| Fair | 7.5x | $22.77 | -22% |
| Forward | 7.6x | $29.07 | — |
| Current | 9.6x | $29.07 | — |
| Expensive | 13x | $39.16 | +35% |
Historical ranges are pointers, not guarantees.
NECB has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
NECB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NECB, with profitability improving.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over NECB on earnings, with more consistent year-over-year improvement.
NECB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.83 | +26% |
| Q3 2026 | $3.03 | -5.6% |
| Q2 2026 | $3.11 | -5.5% |
| Q1 2026 | $3.21 | -6.7% |
| Q4 2025 | $3.25 | -7.7% |
| Q3 2025 | $3.21 | -15% |
| Q2 2025 | $3.29 | -9.4% |
| Q1 2025 | $3.44 | +0.9% |
| Q4 2024 | $3.52 | +6% |
NECB earned $3.03 per share over the past year, down 5.6% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over NECB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
NECB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.1M | -3.2% |
| Q2 2026 | $25.3M | -2.5% |
| Q1 2026 | $24.9M | -2.2% |
| Q4 2025 | $26.4M | +3.9% |
| Q3 2025 | $27M | -2.5% |
| Q2 2025 | $25.9M | -3.8% |
| Q1 2025 | $25.5M | -0.2% |
| Q4 2024 | $25.4M | -4.3% |
NECB's revenue grew through 2023 and has held roughly level since: $26M last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | -3.5 points |
| Q2 2026 | 55% | -4.9 points |
| Q1 2026 | 56% | -1.1 points |
| Q4 2025 | 59% | +2 points |
| Q3 2025 | 62% | -2 points |
| Q2 2025 | 59% | -6.1 points |
| Q1 2025 | 57% | -5.3 points |
| Q4 2024 | 57% | -7.5 points |
NECB has the edge over MS on profitability, with a higher operating margin.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
NECB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11M | -19% |
| Q2 2026 | $12.7M | -15% |
| Q1 2026 | $10.3M | -2.1% |
| Q4 2025 | $11.8M | +17% |
| Q3 2025 | $13.6M | -4.5% |
| Q2 2025 | $14.9M | +35% |
| Q1 2025 | $10.6M | -18% |
| Q4 2024 | $10.1M | -14% |
NECB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over NECB on shareholder dilution, with a more favorable share count trend.
NECB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +28K shares |
| 1 year | -0.5% | -66K shares |
| 3 years | -8.5% | -1.3M shares |
| 5 years | -17% | -2.8M shares |
NECB has 14M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $168,000 |
| Q2 2026 | $1.1M |
| Q1 2026 | $3.6M |
| Q4 2025 | $1.4M |
| Q4 2024 | $726,000 |
| Q3 2024 | — |
| Q2 2024 | $1.2M |
| Q1 2024 | $1.3M |
NECB spent $6M buying back its own shares over the past year.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
NECB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | -1.4x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
NECB has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
NECB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.8 | Neutral |
| Stochastic | 76.8 | Neutral |
NECB's weekly RSI is 70 (neutral) and its Stochastic is 77 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
NECB PE vs Financial Services Sector
| Metric | NECB | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 13x | 26% below |
| PE % | 69 | 63 | 6 pts above |
NECB has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
NECB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.9 | 4.4% above |
| 20 week MA | $27.2 | 6.8% above |
| 50 week MA | $25.3 | 15% above |
| 100 week MA | $23.9 | 22% above |
| 200 week MA | $20.8 | 40% above |
NECB has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
NECB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.80 | $10.3 | +17% |
| 2021 | $10.3 | $11.2 | +8.8% |
| 2022 | $11.2 | $15.0 | +35% |
| 2023 | $15.0 | $17.7 | +18% |
| 2024 | $17.7 | $24.8 | +40% |
| 2025 | $24.8 | $23.0 | -7.3% |
| 2026 YTD | $23.0 | $29.1 | +27% |
NECB has the edge over MS on returns for 2026, with the stronger performance.